Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $25.4500 (4.3%) ($24.4500 - $25.8300) on Fri. Jul. 1, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.35% (three month average) | RSI | 37 | Latest Price | $25.4500(4.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.5% a day on average for past five trading days. | Weekly Trend | EDIT declines -10.5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) ARKG(60%) IBB(59%) XBI(58%) IWO(55%) ARKK(54%) | Factors Impacting EDIT price | EDIT will decline at least -2.175% in a week (0% probabilities). VIXM(-14%) TLT(-7%) SHY(-6%) GDXJ(-4%) UUP(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.175% (StdDev 4.35%) | Hourly BBV | 0 () | Intraday Trend | 4.1% | | | |
|
1 - 5 Day Possible Target | $5.53(-78.27%) | Resistance Level | $28.9 | 5 Day Moving Average | $24.74(2.87%) | 10 Day Moving Average | $26.25(-3.05%) | 20 Day Moving Average | $28.9(-11.94%) | To recent high | -39.5% | To recent low | 6.7% | Market Cap | $1.581b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |